Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Zenabis Global Inc. T.ZENA

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
We are a diverse, passionate team of doctors, scientists, researchers, growers, educators, and advocates who came together with the goal of increasing access to safe, high quality cannabis for medical patients and recreational consumers. Our four facilities are located coast-to-coast across Canada in Delta and Langley, British Columbia; Atholville, New Brunswick; and Stellarton, Nova Scotia. Zenabis currently owns 3.5 million square feet of facility space.


TSX:ZENA - Post by User

Zenabis Global Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(40)
•••
Post by wanttoretireearlyon Feb 13, 2020 10:25am
148 Views
Post# 30685579

Price target $0.43 - upside of 394.25%

Price target $0.43 - upside of 394.25%Based on 2 analysts offering 12 month price targets for Zenabis Global in the last 3 months. The average price target is $0.43 with a high forecast of $0.75 and a low forecast of $0.11. The average price target represents a 394.25% increase from the last price of $0.087.

Moderate Buy

Based on 2 Analyst Ratings

  • 1 Buy
  • 1 Hold
  • 0 Sell

Based on 2 Wall Street analysts offering stock ratings for Zenabis Global in the last 3 months (by analysts ranked 0 to 5 stars).


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities